Global Multiple Myeloma Therapeutics Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast

  • ID:PD014980
  • January 2017
  • Value Market Research
                 

The report on global multiple myeloma therapeutics market evaluates the growth trends of the industry through historical study and estimates future prospects based on comprehensive research. The report extensively provides the market share, growth, trends and forecasts for the period 2015-2022. The market size in terms of revenue (USD MN) is calculated for the study period along with the details of the factors affecting the market growth (drivers and restraints).
 
Drivers

  • Increasing geriatric population
  • Finite powers of the drugs
 
Restraints
  • Many patients suffer decline or ripen treatment resistance which may hamper the market
 
Furthermore, the report quantifies the market share held by the major players of the industry and provides an in-depth view of the competitive landscape. This market is classified into different segments with detailed analysis of each with respect to geography for the study period:
  • Base Year: 2015
  • Estimated Year: 2016
  • Forecast Till: 2022
 
The comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with detailed understanding of the core competency of each activity involved. The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.
 
The report classifies the market into different segments based on type. These segments are studied in detail incorporating the market estimates and forecasts at regional and country level. The segment analysis is useful in understanding the growth areas and probable opportunities of the market.
 
The report also covers the complete competitive landscape of the worldwide market with company profiles of key players such as Amgene, Inc., Bristol-Myers Squibb, Bristol-Myers Squibb Company, Celgene Corporation, Genzyme Corporation, Janssen Biotech, Inc., Juno Therapeutics, Kesios Therapeutics Limited, Millennium Pharmaceuticals, Novartis AG. A detailed description of each has been included, with information in terms of H.Q, future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other latest industrial developments.
 
SEGMENTATIONS IN THE REPORT:
By Type:
  • Chemotherapy and other drugs
    • Traditional chemotherapy
    • Immunomodulating agents
    • Proteasome inhibitors
    • Histone Deacetylase (HDAC) inhibitors
    • Monoclonal Antibodies
  • Radiation
  • Stem cell transplant and supportive treatment
 
By Geography:
  • North America (NA)
  • Europe (EU)
  • Asia Pacific (APAC)
  • Latin America (LA)
  • Middle East & Africa (MEA)
 
METHODOLOGY:
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand. 

  • DecisionDatabases.com also provides specific research reports as per Client requirement.
  • Based on the feasibility, data can be provided for custom segmentation
 
DELIVERABLE OPTIONS:
 
DecisionDatabases.com also provides Mini Report and Sections of Reports, in case Client does not want to buy the full report: 
  • Market Data Sheet with all Tables and Graphs
  • Mini Report
  • Analysis
    • Drivers
    • Restraints
    • SWOT Analysis
    • Patent Analysis
  • Application Analysis
  • Product Analysis
  • Geography Analysis
  • Company Analysis
  • Competitive Landscape
  • Location of Plants
  • Company Profiles

1. INTRODUCTION

  • Report Description
  • Research Scope   
  • Research Methodology   
 
2. EXECUTIVE SUMMARY   
 
3. MARKET ANALYSIS
  • Introduction
  • Value Chain Analysis
  • Drivers   
  • Restraints   
  • Opportunities   
  • Porter’s Five Forces Analysis
 
4. MULTIPLE MYELOMA THERAPEUTICS MARKET ANALYSIS BY TYPE
  • Market In Chemotherapy and other drugs
    • Market In Traditional chemotherapy
    • Market In Immunomodulating agents
    • Market In Proteasome inhibitors
    • Market In Histone Deacetylase (HDAC) inhibitors
    • Market In Monoclonal Antibodies
  • Market In Radiation
  • Market In Stem cell transplant and supportive treatment
 
5. MULTIPLE MYELOMA THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY
  • North America (NA)
    • North America Market Estimates
    • North America Market Estimates By Country
    • United States (U.S.)
    • Rest Of North America
  • Europe (EU)
    • Europe Market Estimates
    • Europe Market Estimates By Country
    • United Kingdom (UK)
    • Germany
    • France
    • Rest Of Europe
  • Asia Pacific (APAC)
    • Asia Pacific Market Estimates
    • Asia Pacific Market Estimates By Country  
    • China
    • Japan
    • India
    • Rest Of Asia Pacific   
  • Latin America (LA)   
    • Latin America Market Estimates
    • Latin America Market Estimates By Country
    • Brazil
    • Rest Of Latin America
  • Middle East And Africa (MEA)   
    • Middle East And Africa Market Estimates
    • Middle East And Africa Market Estimates By Country
    • Middle East
    • Africa
 
6. COMPETITIVE LANDSCAPE OF THE MULTIPLE MYELOMA THERAPEUTICS COMPANIES
  • Market Competition
  • Partnerships/Collaborations/Agreements
  • Mergers And Acquisitions
  • New Product Launches
  • Other Developments
 
7. COMPANY PROFILES OF THE MULTIPLE MYELOMA THERAPEUTICS INDUSTRY
  • Amgene, Inc.
  • Bristol-Myers Squibb
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • Genzyme Corporation
  • Janssen Biotech, Inc.
  • Juno Therapeutics
  • Kesios Therapeutics Limited
  • Millennium Pharmaceuticals
  • Novartis AG
 
* Tentative TOC 

Related Categories
Pharmaceuticals
Related Reports
Global Tigecycline Market Research Report 2017

The Global Tigecycline Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin, cost  read more..


Global Caffeine Market Research Report 2017

The Global Caffeine Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin, cost structure,  read more..


Global Rabies Vaccine Market Research Report 2017

The Global Rabies Vaccine Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin, cost  read more..


United States Parkinson's Disease Drug Industry 2015 Market Research Report

Parkinson's Disease Drug - Definition Parkinson's disease drug is progressive medication to prevent a progressive, degenerative neurological  read more..


Global Radiopharmaceuticals Industry 2015 Market Research Report

Radiopharmaceuticals - Definition Radiopharmaceuticals, also known as Medicinal radiocompounds, are a group of pharmaceutical drugs which have  read more..


Global Neurorehabilitation System Market Research Report

Neurorehabilitation system is as innovative technological solution to monitor and review the activity of nervous systems. It is a relatively new method  read more..


Global Molecular Biology Kits And Reagents Market Research Report

The global molecular biology kits and reagents market is expected to grow at a CAGR of ~7% from 2013 to 2018. A number of factors such as rise in  read more..


Global High Acuity Care Information Systems Market Research Report

The global high acuity care information systems market is expected to grow at a CAGR of ~4% from 2013 to 2018. A number of factors such as growing focus  read more..


Global Regenerative Medicine Market Research Report

The global regenerative medicine market was estimated to be at ~$4.5 billion in 2013.   A number of factors such as increasing bone related  read more..


Global Skin Cancer Diagnostics Market Research Report

Cancers of skin tissues are one of the major types of cancers in the world. In recent years, more than 40% of all cancers in the U.S. have been skin  read more..